Work

Lenalidomide, Bortezomib, and Dexamethasone (RVD) in Combination with Vorinostat As Front-Line Therapy for Patients with Multiple Myeloma (MM): Results of a Phase 1 Study

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.336.336

Authors: Jonathan L. Kaufman, Jatin J. Shah, Jacob P. Laubach, Alaina R. Mitchell, Cathy Sharp, Colleen Lewis, R. Donald Harvey, Charise Gleason, Daniela Casbourne, Ajay K. Nooka, Leonard T Heffner, Paul G. Richardson, Robert Z. Orlowski, Sagar Lonial

Institutions: Winship Cancer Institute, The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Emory University, Harvard University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2538744143

FWCI: 3.164

Cites:

Cited by: 18

Related to: 10